At the IGTP TODAY

News

- Research

New guidelines for parasite studies using extracellular vesicles

A collaborative document outlining new guidelines for the isolation and characterisation of extracellular vesicles in parasitic disease research has been published in the Journal of Extracellular Biology. A research group from IGTP and ISGlobal contributed to the study, which could enhance our understanding of host-parasite interactions and advance early diagnosis, treatment, and prevention of parasite-caused diseases.

- Research

Apotransferrin shows promise as an early treatment for stroke

Researchers from IGTP have discovered that administering human apotransferrin to mice models affected by intracerebral haemorrhage can mitigate the damaging effects of this severe type of stroke. This finding highlights the promising role of apotransferrin as a pre-hospital and pre-triage frontline treatment for all stroke patients. The study has been published in the journal Antioxidants.

- Research

Type 1 diabetes research sheds light on biomarkers in partial remission phase

Researchers from the IGTP have led a comprehensive review study on biomarkers for the often-overlooked partial remission phase of type 1 diabetes, in collaboration with experts in β-cell biology and regeneration from the Diabetes Research Institute in Miami. The study has been published in the journal Trends in Endocrinology and Metabolism.

Artificial intelligence and advanced therapies are the focus of the ICS Conference, hosted by IGTP

The 14th Research Conference of the ICS focused on the transformative potential of research in the health system and awarded prizes to eight researchers. Antoni Bayés and Alejandro Bustamante, who work at the Hospital and researchers at IGTP, were awarded a prize for the best hospital scientific career and ICS young researcher, respectively.